Publication | Open Access
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
40
Citations
43
References
2021
Year
MIDs for the EORTC QLQ-C30 scales generally ranged between 4 and 11 points for both within-group mean change and between-group mean difference in change. These results can be used to interpret QLQ-C30 results from glioma trials.
| Year | Citations | |
|---|---|---|
Page 1
Page 1